Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly PROCRIT in Diabetic Subjects with Anemia of CKD
NCT00240734Phase 2Terminated
- Sponsor
- Johnson & Johnson
- Start
- Mar 2005
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 2 trial of epoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Johnson & Johnson. Started Mar 2005; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00240734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240734.